University of Pennsylvania Health System
Dr. Haas' main clinical interest lies in the diagnosis and staging of lung cancer, utilization of advanced diagnostic modalities for pulmonary nodule biopsy, lung cancer screening, evaluation and management of benign and malignant airway obstruction and management of pleural disease. His reseach interest revolve around device develeopment and assessment, novel immunotherapeutic approaches for mesothelioma and lung cancer including chimeric antigen receptor T cells and immunostimulatory viral vectors.
Bristol Myer Squibb (Individual(s) Involved: Self): Consultant; Mana therapeutics (Individual(s) Involved: Self): Consultant; Novocure (Individual(s) Involved: Self): Advisory Board, DSMB; Olympus America, Inc. (Individual(s) Involved: Self): Consultant; Serpex Medical (Individual(s) Involved: Self): Advisory Board, Consultant; VisionAir (Individual(s) Involved: Self): Advisory Board
Friday, August 26, 2022
12:10 PM – 1:50 PM
Friday, August 26, 2022
12:15 PM – 12:30 PM
Friday, August 26, 2022
1:30 PM – 1:50 PM